跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Cisaphtin-10
Approved
STANDARD
Cisaphtin-10
Bruck Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b5c205ebd93eb1fe
Company
Bruck Pharma Private Limited
Type
Standard
Approval Details
Approval Id
b5c205ebd93eb1fe
Drug Approval Philippines Name
Cisaphtin-10
Product Name
Cisaphtin-10
Registration Number
DRP-11189
Brand Name
Cisaphtin-10
Generic Name
Cisplatin
Dosage Form
Lyophilized Powder for Injection (IV Infusion)
Dosage Strength
10 mg
Manufacturer
Bruck Pharma Private Limited
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 April 2023
Expiry Date
11 February 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b5c205ebd93eb1fe
Type
Standard
Back to Philippines FDA Approvals
Cisaphtin-10 - Philippines FDA Drug Approval Details